117 related articles for article (PubMed ID: 12440819)
1. Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
Tamiolakis D; Simopoulos C; Cheva A; Lambropoulou M; Kotini A; Jivannakis T; Papadopoulos N
Eur J Gynaecol Oncol; 2002; 23(5):433-6. PubMed ID: 12440819
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
Yakirevich E; Izhak OB; Rennert G; Kovacs ZG; Resnick MB
Mod Pathol; 1999 Nov; 12(11):1050-6. PubMed ID: 10574602
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast.
Yakirevich E; Maroun L; Cohen O; Izhak OB; Rennert G; Resnick MB
J Pathol; 2000 Oct; 192(2):166-73. PubMed ID: 11004692
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
[TBL] [Abstract][Full Text] [Related]
5. Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast.
Lim KH; Telisinghe PU; Abdullah MS; Ramasamy R
Cancer Immun; 2010 Jan; 10():3. PubMed ID: 20092246
[TBL] [Abstract][Full Text] [Related]
6. CD8+ lymphocytes and apoptosis in typical and atypical medullary carcinomas of the breast.
Nurlaila I; Telisinghe PU; Ramasamy R
Immunol Lett; 2013; 156(1-2):123-6. PubMed ID: 24120509
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast.
Kuroda H; Tamaru J; Sakamoto G; Ohnisi K; Itoyama S
Virchows Arch; 2005 Jan; 446(1):10-4. PubMed ID: 15660281
[TBL] [Abstract][Full Text] [Related]
8. Fine-needle aspiration of breast carcinomas with prominent lymphocytic infiltrate.
Kleer CG; Michael CW
Diagn Cytopathol; 2000 Jul; 23(1):39-42. PubMed ID: 10907931
[TBL] [Abstract][Full Text] [Related]
9. Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast.
Guo X; Fan Y; Lang R; Gu F; Chen L; Cui L; Pringle GA; Zhang X; Fu L
Mod Pathol; 2008 Sep; 21(9):1101-7. PubMed ID: 18469794
[TBL] [Abstract][Full Text] [Related]
10. Gains and losses of CD8, CD20 and CD56 expression in tumor stroma-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and lymphocytes from tumor draining lymph nodes in serous papillary ovarian carcinoma patients.
Papadopoulos N; Kotini A; Cheva A; Jivannakis T; Manavis J; Alexiadis G; Lambropoulou M; Vavetsis S; Tamiolakis D
Eur J Gynaecol Oncol; 2002; 23(6):533-6. PubMed ID: 12556098
[TBL] [Abstract][Full Text] [Related]
11. Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance.
Gaffey MJ; Frierson HF; Mills SE; Boyd JC; Zarbo RJ; Simpson JF; Gross LK; Weiss LM
Mod Pathol; 1993 Nov; 6(6):721-8. PubMed ID: 8302815
[TBL] [Abstract][Full Text] [Related]
12. In breast cancer, a high ratio of tumour-infiltrating intraepithelial CD8+ to FoxP3+ cells is characteristic for the medullary subtype.
Anz D; Eiber S; Scholz C; Endres S; Kirchner T; Bourquin C; Mayr D
Histopathology; 2011 Nov; 59(5):965-74. PubMed ID: 22092408
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating CD45RO(+) memory cells are associated with a favorable prognosis breast cancer.
Yajima R; Yajima T; Fujii T; Yanagita Y; Fujisawa T; Miyamoto T; Tsutsumi S; Iijima M; Kuwano H
Breast Cancer; 2016 Jul; 23(4):668-74. PubMed ID: 26071015
[TBL] [Abstract][Full Text] [Related]
14. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients.
Ahmadvand S; Faghih Z; Montazer M; Safaei A; Mokhtari M; Jafari P; Talei AR; Tahmasebi S; Ghaderi A
Cell Oncol (Dordr); 2019 Jun; 42(3):343-356. PubMed ID: 30825183
[TBL] [Abstract][Full Text] [Related]
15. Multiplexed quantitative analysis of CD3, CD8, and CD20 predicts response to neoadjuvant chemotherapy in breast cancer.
Brown JR; Wimberly H; Lannin DR; Nixon C; Rimm DL; Bossuyt V
Clin Cancer Res; 2014 Dec; 20(23):5995-6005. PubMed ID: 25255793
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic Features and Immune Cell Subtypes Analysis of Tumor-infiltrating Lymphocytes Rich Invasive Breast Carcinoma of No Special Type.
Zhao Y; Huang T; Jin X; Gong XM; Lu YZ
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):354-362. PubMed ID: 37278279
[TBL] [Abstract][Full Text] [Related]
17. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
18. Levels of different subtypes of tumour-infiltrating lymphocytes correlate with each other, with matched circulating lymphocytes, and with survival in breast cancer.
Verma R; Hanby AM; Horgan K; Verghese ET; Volpato M; Carter CR; Hughes TA
Breast Cancer Res Treat; 2020 Aug; 183(1):49-59. PubMed ID: 32577938
[TBL] [Abstract][Full Text] [Related]
19. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.
Rathore AS; Kumar S; Konwar R; Makker A; Negi MP; Goel MM
Indian J Med Res; 2014 Sep; 140(3):361-9. PubMed ID: 25366203
[TBL] [Abstract][Full Text] [Related]
20. Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype.
Orlando L; Renne G; Rocca A; Curigliano G; Colleoni M; Severi G; Peruzzotti G; Cinieri S; Viale G; Sanna G; Goldhirsch A
Ann Oncol; 2005 Jul; 16(7):1094-9. PubMed ID: 15855225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
